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Edited by Francesc PosasAbstract Using a chemical genetic approach, we identiﬁed four
novel physiological substrates of Hog1 kinase (Krs1, Tdh3,
Hsp26, and Shm2). These substrates suggest plausible mecha-
nisms for actin reorganization, cell cycle arrest and regulation
of protein synthesis observed upon osmotic stress. We further
show that the human homolog of Shm2 (SHMT1) is a novel
physiological substrate of p38 MAP kinase in vitro and
in vivo. Down-regulation of its enzymatic activity was observed
following p38-mediated phosphorylation revealing a potential
cancer-modulating property of p38 MAP kinase. This screen
has uncovered several novel Hog1 substrates that provide new
avenues for investigation into the mechanism of osmoadaptation
by this kinase.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The budding yeast, Saccharomyces cerevisiae, rapidly adapts
to increases in osmolarity in the extracellular environment by
activating the high osmolarity glycerol (HOG) MAPK cas-
cade. This cascade is essential for the survival of yeast in high
osmolarity environment, as deletion of Hog1 kinase, a key
player involved in this pathway, is lethal [1]. Several indepen-
dent studies using DNA microarrays have revealed a vast
number of genes induced by osmotic stress [2–7]. Since the
hog1 deletion yeast strain does not survive under osmotic
stress, it suggests that the expression of the majority of these
genes must depend on Hog1 protein. Two independent studies
have [6,7] addressed this question using wild-type (wt) and
hog1 deletion strains of S. cerevisiae and showed that 80%
and 50% of the genes, respectively, responding to osmotic
stress were dependent on Hog1.
Osmotic stress activates multiple pathways for stress adapta-
tion including glycerol production, temporary cell cycle arrest,
down regulation of protein synthesis, actin reorganization,
expression changes in carbon metabolism, stress response
and transcription and translation of a set of chaperone pro-*Corresponding author. Fax: +1 765 494 0239.
E-mail address: shah23@purdue.edu (K. Shah).
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are known to mediate these eﬀects. Many of these are tran-
scription factors including Msn2/Msn4 [8], Sko1 [9], Hot1
[10] and Smp1 [11]. Msn2 and Msn4 respond to various envi-
ronmental stresses in S. cerevisiae [12], whereas Sko1 speciﬁ-
cally responds to osmotic stress [6]. Hot1 controls the
expression of GPD1 and GPP genes that are important for
glycerol production under high osmolarity conditions [13].
Overexpression of SMP1 induces Hog1-mediated expression
of osmoresponsive genes such as STL1 [11]. Hog1-dependent
phosphorylation of Hsl1 kinase leads to a G2 arrest, which
is essential for cell survival at high osmolarity [14]. Another
known substrate of Hog1 is the protein kinase Rck2, which
also regulates a subset of the genes activated upon osmotic
stress [15]. Sic1 phosphorylation has shed light on the mecha-
nism of Hog1-mediated G1 arrest [16,17]. Hog1 recruits Rpd3
histone deacetylase to promote the modiﬁcation of the chro-
matin at the promoters to activate osmoresponsive genes
[18]. In addition, Hog1 also acts as a selective elongation factor
for genes induced by osmotic stress [19]. In summary, multiple
studies involving Hog1 kinase have uncovered the complexity
and redundancy of its upstream activators and downstream
functions and eﬀectors of Hog1. In the present study, we have
reexamined the role of Hog1 by using a chemical genetic tool,
which allows for the identiﬁcation of its direct substrates in the
presence of the whole proteome.
We engineered a sensitizing mutation that renders Hog1 spe-
ciﬁcally and temporally controllable by a small molecule inhib-
itor [20] in addition to being capable of utilizing an orthogonal
ATP analog [21]. The analog sensitive mutant allele of HOG1
(hog1-as1) was created by the replacement of a conserved
bulky residue with a glycine (T100G) in the active site. The
complementary ‘‘bump’’ was created by attaching bulky sub-
stituents to ATP or to pyrazolo-pyrimidinel (PP1) derived
inhibitors. The sensitized allele engineered by this mutation
has been shown to possess identical substrate speciﬁcity com-
pared to the wt kinase [22–24]. The sensitization of the kinase’s
active site for a speciﬁc structurally modiﬁed [c-32P] labeled
nucleotide analog provides a unique handle by which the direct
substrates of any particular kinase can be traced in the pres-
ence of other protein kinases. Similarly, a cell-permeable,
chemically modiﬁed ‘‘bumped’’ inhibitor in the presence of
an analog sensitive mutant kinase is an extremely potent tool
for dissecting the role of any kinase of interest in vivo [24–27].
We identiﬁed four novel in vivo substrates of Hog1 in yeast
cell extracts using Hog1-as1 and N6(Phenethyl)ATP (PE-
ATP). Speciﬁcally, the mammalian homolog of one of the novel
substrates of Hog1 (SHMT1) is known to be highly expressedblished by Elsevier B.V. All rights reserved.
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atomas and rat sarcomas [28]. We further demonstrate that it is
a direct substrate of human p38 MAP kinase. Phosphorylation
of SHMT1 by p38 reduces its enzymatic activity, suggesting a
potential cancer-modulating property of p38 MAP kinase.2. Materials and methods
2.1. Yeast strains and osmosensitive phenotype assay
Strain RSY580 (MATa ura3-52, trp1D63, leu2D1) was a generous
gift from Paul Ferrigno. Yeast media were prepared as described
[29]. Yeast transformations were performed using lithium acetate pro-
cedure [30]. The plasmid shuﬄe method was performed as previously
described [31] using 5-ﬂuoroorotic acid (5-FOA). For genomic integra-
tion, the hog1 gene containing the T100G substitution was transformed
into the RSY580 strain and FOA-resistant candidate strains were iso-
lated. The hog1 mutant alleles were veriﬁed by the gap repair method
[32]. To test the osmosensitive phenotype of the hog1 mutant strains,
cultures of both wt and hog1-as1 mutant strains were serially diluted
and spotted onto YPD plates containing 0.9 M NaCl or 0.9 M NaCl
plus 1-NM-PP1 in varying concentrations (0.5–5 lM).
2.2. Preparation of [c-32P] N6(Phenethyl)ATP
[c-32P] N6(Phenethyl)ATP was synthesized as described before [22].
2.3. Preparation of Hog1 kinase and in vitro kinase assay
The Hog1 proteins were expressed as GST-fusion proteins using
pXZ134 (gift from Dr. Xiaoli Zhan, UC Berkeley) from hog1 deletion
strain. For activation of Hog1 kinase, constitutively active Pbs2 kinase
(Pbs2-EE) [33] was generated in E. coli. Constitutively active Hog1 ki-
nase was created by substituting phenylalanine 318 by serine [34] and
puriﬁed as described previously [35]. The enzymatic activity of the
Hog1 kinase was measured with MBP as described previously [20]. Ac-
tive p38a MAP kinase was purchased from Upstate Inc. (Waltham,
MA).
Whole cell lysate (WCL) from S. cerevisiae was prepared as de-
scribed [36]. WCL was fractionated with P-11 column (Whatman) by
step-elution with increasing concentration of potassium acetate
(100 mM, 200 mM, 400 mM, 600 mM, and 1 M). For in vitro labeling
of yeast proteins fromWCL or from fractionated lysate was performed
as described [24].
2.4. In vivo substrate labeling
Phosphate-depleted selective media was prepared as described previ-
ously with minor modiﬁcations [35]. The hog1-as1 mutant strain con-
taining each candidate gene was generated by transforming the
expression construct of each candidate gene (pYEX-4T, gift from Eliz-
abeth Winzeler). Same volume of cultures were harvested at 0, 5, 10, 20
and 40 min, cell lysate was prepared and GST-fused protein was cap-
tured by glutathione sepharose beads (Pharmacia). Labeled proteins
were detected using 8–12% gradient SDS PAGE gels, electroblotting
on PVDF membrane and autoradiography.
2.5. 2D gel electrophoresis and MS spectrometry
20–40 lg ofWCLor fractionated lysates were labeled in a kinase reac-
tion as described above. 2D gel electrophoreses of labeled samples were
carried out by Kendrick Labs (Madison, Wisconsin) with 2% pH 4–10
ampholines at 9600 V h. The gels were strainedwithCoomassie Brilliant
Blue R-250, dried and exposed to Kodak X-OMAT AR ﬁlm. Gel spots
were manually excised and automatically processed for peptide map-
ping experiments using aMicromassMassPREP Station in conjunction
with manufacturer speciﬁed protocols. MALDI mass spectra were ob-
tained automatically using a Micromass M@LDI-R TOF MS, with
ACTH fragments 18–39 as a Lockmass reference. Protein identiﬁcation
searches were performed using MASCOT (Matrix Sciences).
2.6. Enzymatic assay for serine hydroxylmethyltransferase 2 (Shm2)
GST-Shm2 was puriﬁed from a yeast strain as described above and
its enzymatic activity was measured as described earlier [33] with minor
modiﬁcations. To measure the eﬀect of either Hog1-as1 or p38 kinases,Shm2 enzyme was pre-incubated with each kinase in the presence of
either 1 mM PE-ATP (for Hog1-as1) or 1 mM ATP (for p38) for
30 min at RT before adding to the reaction mixture.
2.7. Transfection and retroviral infection
SHMT1 (human homolog of yeast Shm2) with a C-terminal myc tag
was cloned into pBabe puro plasmid and was transiently transfected
into Bosc 23 cells using Eﬀectene (Qiagen) as manufacturer’s protocol.
The harvested retrovirus was added to 5 · 105 HEK293 cells for infec-
tion. After 48 h the infected cells were selected in the presence of
2.5 lg/mL of puromycin. SHMT1-HEK293 cells were cultured in
DMEM with 10% Bovine Calf Serum (BCS) and were serum-starved
for 24 h in DMEM with 0.5% BCS.3. Results
3.1. 1-NM-PP1 is a potent inhibitor of Hog1-as1 kinase
To ascertain the most potent orthogonal inhibitor for Hog1-
as1 kinase, a series of PP1-derived inhibitors were tested in
in vitro kinase assays with both wt and mutant Hog1 kinase
using myelin basic protein (MBP) as a substrate [20] (data
not shown). Our screening revealed 1-NM-PP1 as an extremely
potent inhibitor of Hog1-as1 (IC50  100 nM) with no eﬀect
on wt Hog1 even at mM concentrations. Therefore, it was used
as the orthogonal inhibitor of choice for the present studies.
Importantly, a recent study employed a similar chemical genet-
ic approach for Hog1 kinase and created analog-sensitive mu-
tant Hog1 kinase by mutating T100A (Hog1-as2). Hog1-as2 is
also speciﬁcally inhibited by 1-NM-PP1 [38]. This study
showed that the catalytic activity of Hog1 prevents cross talk
between the HOG pathway and both the pheromone response
and invasive growth pathways. In addition, it also showed that
the kinase activity of Hog1 is necessary for its stress-induced
nuclear import [38].3.2. Speciﬁc inhibition of Hog1-as1 using 1-NM-PP1 confers
an osmosensitive phenotype
hog1-as1 mutant strains were generated by replacing the wt
allele on genomic DNA with the mutant allele (T100G). To
minimize the eﬀect of genetic manipulation, the breakpoint
for genomic integration of mutant DNA was chosen to ensure
that the original promoter of the wt HOG1 allele would still
express the replaced mutant allele. Sequence analyses allowed
us to select six diﬀerent strains (hog1–8, –17, –23, –25, –27
and –34) harboring the desired mutation in the hog1 gene.
The gap-repair method, followed by sequencing, was used to
further verify the absence of undesired mutations in the hog1
gene.
As shown in Fig. 1A, the growth of all as1 mutant strains
was similar to that of the wt strain, both in the absence (panel
1) and presence of either 0.4 M NaCl or 0.9 M NaCl (panels 2
and 3), conﬁrming our previous observation that as1 mutation
is a functionally silent mutation [23]. In order to investigate
whether treatment of the hog1-as1 mutant strain with the
orthogonal inhibitor indeed confers an osmosensitive pheno-
type similar to that of the hog1 deletion strain, both wt and
mutant hog1 strains were subjected to diﬀerent concentrations
of 1-NM-PP1 in the presence of salt. Five diﬀerent as1 mutant
strains (hog1–8, –17, –23, –25, –27 and –34) displayed clear
growth defects in the presence of increasing concentrations
of the inhibitor (Fig. 1B, compare panel 6 with panels 7–10).
In contrast, the wt strain did not show any growth defect even
AB
Fig. 1. Hog1-as1 mutation is a functionally silent mutation. (A) Osmosensitivity of wt HOG1, hog1 deletion and hog1-as1 strains on YPD medium
(1) or YPD medium containing 0.4 M NaCl (2) or 0.9 M NaCl (3). (B) Strains indicated in (A) were plated on YPD medium (1) or YPD medium
containing 0.5 lM 1-NM-PP1 (2), 1 lM 1-NM-PP1 (3), 2 lM 1-NM-PP1 (4), 5 lM 1-NM-PP1 (5), 0.9 M NaCl (6), 0.9 M NaCl and 0.5 lM 1-NM-
PP1 (7), 0.9 M NaCl and 1 lM 1-NM-PP1 (8), 0.9 M NaCl and 2 lM 1-NM-PP1 (9) or 0.9 M NaCl and 5 lM 1-NM-PP1 (10).
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Moreover, all strains grew equally well in the presence of
1-NM-PP1, when salt was absent from the medium (panels
1–5). These results conﬁrm that Hog1-as1 kinase fully comple-
ments its wt counterpart and confers osmosensitivity to the
strain only in the presence of 1-NM-PP1.
3.3. Screening of A*TP analogs reveals N6(phenethyl)ATP
as the most optimal substrate for Hog1-as1 kinase
To further deconvolute the Hog1 dependent pathway, we
next wanted to carry out an independent global tagging of di-
rect substrates in yeast WCL using Hog1-as1 and an ATP ana-
log in an in vitro kinase reaction. Since recombinant Hog1
protein needs to be activated by its upstream kinase Pbs2 prior
to kinase assays, a constitutively active form of Pbs2 (Pbs2-
EE) was expressed and used for activation [33] In addition,
we also constructed a constitutively active mutant of Hog1-
as1 (CA-Hog1-as1), which eliminated the additional activating
step [34]. We further conﬁrmed that CA-Hog1-as1 had identi-
cal substrate speciﬁcity as that of Hog1-as1 and was more ac-
tive than Hog1-as1 activated by Pbs2-EE (data not shown). To
identify the most optimal orthogonal phospho-donor for the
engineered kinase, a panel of [c-32P]A*TP analogs [21] were
screened in an in vitro kinase reaction with wt Hog1, Hog1-
as1 and CA-Hog1-as1 using MBP as a substrate. The incorpo-
ration of radioactivity onto MBP using N6(Phenethyl)ATP
(PE-ATP) with both Hog1-as1 and CA-Hog1-as1 was 10-foldhigher than with other ATP analogs and 80-fold higher when
compared to ATP. In contrast, wt Hog1 kinase displayed neg-
ligible incorporation of radioactivity when PE-ATP was used.
Both Hog1-as1 and CA-Hog1-as1 showed higher kcat/km and
lower km values for PE-ATP in comparision with ATP (Table
1). Based on these results, [c-32P] PE-ATP was chosen as the
orthogonal phosphodonor to identify the direct substrates of
Hog1 in the present studies.
3.4. Global substrate analysis using 2D electrophoresis and [c-32P]
ATP analog reveals a set of direct Hog1 targets
Preliminary results using WCL showed that Hog1-as1 spe-
ciﬁcally phosphorylates multiple proteins in the presence of
[c-32P] PE-ATP (compare lanes 1–3 in Fig. 2A). Our results
also conﬁrmed that labeling with PE-ATP was completely
dependent on the presence of Hog1 mutant kinase (compare
lanes 3–4). In contrast, the labeling pattern with ATP was
not dependent on Hog1 addition as expected (compare lane
1 to lane 2 in Fig. 2A). Taken together, these results conﬁrmed
that Hog1-as1 preferentially utilizes [c-32P] PE-ATP and thus
phosphorylates its direct substrates in presence of all other ki-
nases. As a control, phosphorylation of recombinant Hog1-as1
with ATP and PE-ATP revealed only Hog-1 autophosphoryla-
tion (Fig. 2B). The direct substrates of Hog1 were analyzed on
a global scale from the entire protein repertoire using [c-32P]
PE-ATP, resolved by 2D gel electrophoresis and identiﬁed
by mass-spectrometry. In initial attempts using WCL, most
Fig. 2. Hog1-as1 mutant kinase preferentially utilizes ATP-analog and labels yeast proteins from lysate speciﬁcally. (A) Autoradiogram of labeled
proteins from WCL after incubation with either [c-32P] ATP (lanes 1 and 2) or [c-32P] N6(Phenethyl)ATP (lanes 3 and 4) in the presence of either
constitutively-active Hog1-as1 mutant kinase (lanes 1 and 3) or buﬀer (lanes 2 and 4). The arrow indicates the position of GST-Hog1 protein on the
gel. (B) Autoradiogram of CA-Hog1-as1 with [c-32P] ATP (lane 1) and [c-32P] N6(Phenethyl)ATP (lane 2). The arrow indicates the position of GST-
Hog1 protein on the gel. (C) Coomassie stain and autoradiogram of 2D gel separating labeled yeast proteins from diﬀerent fractions obtained by
phosphocellulose fractionation, (i) ﬂow-through, (ii) elution fraction with 0.1 M potassium acetate (KOAc), (iii) 0.2 M KOAc, (iv) 0.4 M KOAc, (v)
0.6 M KOAc and (vi) 1.0 M KOAc. Numbers in black indicate the spots for Krs1, Tdh3, Hsp26 and Shm2 (1–4). (D) In vivo labeling experiments
reveal several direct targets of Hog1 kinase. Autoradiogram of each candidate protein from hog1-as1 strain treated with DMSO followed by water
(lanes 1–5), with DMSO followed by 0.9 M NaCl (lanes 6–10), or with inhibitor 1-NM-PP1 followed by 0.9 M NaCl (lanes 11–15). Cells were
harvested at 0 min, 5 min, 10 min, 20 min and 40 min after salt was added (as indicated at the top of the ﬁgure) and were processed as described in the
experimental section. Speciﬁc labeling of Hot1 by Hog1 was included as a control.
Table 1
Kinetic parameters of wild-type Hog1 kinases
Enzyme ATP N6(Phenethyl)ATP
Kcat (min
1) km (lM) Kcat/Km (min
1 M1) Kcat (min
1) km (lM) Kcat/Km (min
1 M1)
wt Hog1 5 170 2.9 · 104 N.D. N.D. N.D.
Hog1-as1a 3.8 305 1.2 · 104 2 7.4 2.7 · 105
CA-Hog1-as1 2 177 1.1 · 104 0.5 3.2 1.6 · 105
N.D.: not determined due to poor utilization of ATP analog by wild-type kinase.
Kinetic parameters of wild-type Hog1 kinase (wt Hog1), Hog1-as1 and constitutively active Hog1-as1 mutant kinase (CA-Hog1-as1). The enzymatic
activity of the Hog1 kinase was measured with myelin basic protein as described previously [29]. The enzyme concentration used in these assays was
6 nM. The reactions were carried out for 30 min in the presence of either [c-32P] ATP or [c-32P] N6 (Phenethyl) ATP.
aHog1-as1 was activated by Pbs2-EE.
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coomassie stained gels. Therefore, a large scale fractionation
(from 1 kg cell pellet) of WCL was carried out using cationexchange chromatography to enrich proteins in diﬀerent frac-
tions. Fractions eluted with six diﬀerent salt concentrations
were collected, concentrated and subjected to in vitro labeling
S. Kim, K. Shah / FEBS Letters 581 (2007) 1209–1216 1213assays. Fractionation of WCL substantially helped enrich the
proteins on 2D gels and 40 spots were chosen based on their
intensity of labeling and coomassie staining on gel (Fig. 2C,
i–vi) and analyzed by Micromass MassPREP Station. Based
on the matching molecular weight (MW) and isoelectric point
(pI) on 2D gel and the presence of possible Hog1 consensus
phosphorylation sites (S/TP), 12 diﬀerent proteins were se-
lected as putative direct substrates of Hog1.
One caveat of the WCL screen for direct Hog1 substrates is
the possibility that substrate phosphorylation in the cell lysate
may not accurately recapitulate phosphorylation events in the
intact cells. Therefore, to conﬁrm whether these putative tar-
gets were indeed Hog1 substrates in vivo, all 12 constructs wereA B
C D
E F
Fig. 3. Phosphorylation by p38a reduces Shm2 and SHMT1 activity. (A) Aut
buﬀer (lane 3) in the kinase reaction using [c-32P] PE-ATP. For control, Hog
arrows indicate the positions of GST-Hog1 and GST-Shm2 proteins on the
alone (ﬁrst column) and Hog1-as1 and PE-ATP (second column). The percen
Shm2 activity without Hog1 incubation as 100% from two independent assa
(lane 2) or buﬀer (lane 3) in the kinase reaction using [c-32P] ATP. For contro
arrows indicate the positions of GST-SHMT1 and p38a proteins on the gel.
(ﬁrst column) and p38a and ATP (second column). (E) Reduced SHMT1 act
cells were left untreated (column 1) or treated for 15 min (column 2) or 30 min
by immunoblot using anti-myc antibody (‘SHMT1’). (F) SHMT1 activity was
or with MKK6b-EE (column 2). The amount of SHMT1 was visualized by im
myc antibody (‘SHMT1’). Phosphorylation of p38a from equal protein amou
the phosphorylated form of p38a (‘p38a’).expressed as GST-tagged proteins in the hog1-as1 strain and
were subjected to in vivo labeling experiments as described
above. Under these experimental conditions, only four candi-
date proteins showed a phosphorylation pattern similar to that
of Hot1 (positive control, Fig. 3D) that was dependent on salt
addition and inhibition by 1-NM-PP1 in an in vivo assay.
There are two possibilities to explain this result; ﬁrst, phos-
phorylation of some of the candidate proteins might be ham-
pered by the GST moiety. The second possibility is that an
abundant protein might be masking the signal of the true radi-
olabeled substrate of Hog1 in the mass spectral analysis by
virtue of being at the same spot on a 2D gel. Despite
these experimental limitations, our results show that Krs1oradiogram of labeled Shm2 after incubation with Hog1-as1 (lane 2) or
1-as1 (lane 1) was added into the reaction mixture without Shm2. The
gel. (B) Shm2 enzymatic activities after pre-incubation with PE-ATP
tage of Shm2 activity with Hog1 incubation was calculated by setting
ys. (C) Autoradiogram of labeled SHMT1 after incubation with p38a
l, p38a (lane 1) was added into the reaction mixture without Shm2. The
(D) SHMT1 enzymatic activities after pre-incubation with ATP alone
ivity upon sorbitol-induced osmotic stress. Serum-starved SHMT1-293
(column 3) with 0.3 M sorbitol. The amount of SHMT1 was visualized
measured from SHMT1-293 cells transfected with no DNA (column 1)
munoblot with 1/10th of the immunoprecipitated material using anti-
nts of WCL was visualized by immunoblot using an antibody against
1214 S. Kim, K. Shah / FEBS Letters 581 (2007) 1209–1216(1ysy1-tRNA synthetase), Tdh3 (glyceraldehyde-3-phosphate
dehydrogenase), Hsp26 (heat shock protein 26) and Shm2 (ser-
ine hydroxylmethyltransferase) are phosphorylated in a Hog1
dependent manner in vivo upon osmotic shock.
3.5. Hog1-mediated phosphorylation modulates the enzymatic
activity of Shm2 in vitro
One of the direct substrates of Hog1, Shm2, is noteworthy
since several groups have reported elevated SHMT1 (the mam-
malian counterpart of yeast Shm2) activity in various cancer
cells and tumor tissues [28]. Therefore, we next investigatedFig. 4. Novel substrates and proposed regulatory pathways controlled by Ho
as a blue arrow) from outside the cell converges onto Pbs2 MAPKK (co
phosphorylation). Phosphorylation of target proteins (colored green for subst
were identiﬁed in previous studies) may presumably modulate multiple ce
homology between yeast and mammalian signaling pathways controlled by
kinase are indicated on the left-hand side of the ladder (in green), togeth
mammalian proteins known to be downstream of p38a are indicated with soli
p38a in this study. The mammalian homologs which have not been identiﬁ
indicated with grey arrows and question marks. The mammalian homologswhether this phosphorylation event plays any role in control-
ling its activity. Since GST-Shm2 expressed in S. cerevisiae
was found to be eﬃciently phosphorylated in an in vitro kinase
assay by Hog1 (Fig. 3A, compare lanes 2 and 3 for Hog1), we
next measured the transfer of C14-labeled one-carbon unit to
determine Shm2 activity [37]. As shown in Fig. 3B, Hog1 depen-
dent phosphorylation down-regulates Shm2 enzymatic activity
in vitro. It suggests that there are alternate pathways at the post-
translational level to divert biosynthetic activities of yeast cells
from cell proliferation to cell survival upon osmotic stress, in
addition to controlling at the transcriptional level [3,6].g1 kinase upon osmotic stress. (A) The signal of osmotic stress (shown
lored blue) which activates Hog1 kinase (shown in red and ‘P’ for
rates that were identiﬁed in our study, colored black for substrates that
llular processes (red, right-hand side). (B) High degree of functional
Hog1 and p38a. The newly identiﬁed downstream eﬀectors of Hog1
er with the known substrates of Hog1 (in black). The homologous
d arrows. SHMT1 (in red) was identiﬁed as a physiological substrate of
ed or which are not proven to be involved in the p38a pathway are
in bold are referring to a family of proteins.
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activity of Shm2 in vitro and in vivo
We next investigated whether p38a MAP kinase (human
homolog of Hog1) has the same ability to control Shm2 or
SHMT1 activity. In vitro kinase assays using p38a revealed
both Shm2 (Fig. 3C, compare lanes 2 and 3) and SHMT1 (data
not shown) as direct substrates of p38 MAP kinase. More
importantly, our results showed a strong modulation of both
Shm2 and SHMT1 enzymatic activities upon phosphorylation
by p38 MAP kinase in vitro (50% for Shm2 in Fig. 3D and
30% for SHMT1 in Fig. 4E, respectively). To further investi-
gate whether SHMT1 was also an in vivo target of p38 MAP
kinase, myc-tagged SHMT1 expressing HEK293 stable cells
were generated. The p38 MAP kinase pathway was stimulated
using sorbitol in HEK293 and SHMT1-HEK293 cells, which
showed phosphorylation of p38 in a time-dependent manner
as reported earlier [39]. SHMT1 was immunoprecipitated at
diﬀerent time points after stimulation and its enzymatic activ-
ity was measured as described above. Our results displayed de-
creased activity of SHMT1 as a result of sorbitol treatment
(Fig. 3E, compare lanes 2 and 3 with lane 1). Since the sorbi-
tol-induced pathway is also known to enhance JNK activation,
in addition to that of p38 [40], we next generated the constitu-
tively active form of MKK6b (MKK6b-EE), which only acti-
vates p38 [39]. Transient transfection of MKK6b-EE resulted
in the activation of p38 and a strong modulation of SHMT1
activity (Fig. 3F). These results clearly suggest that p38a has
the ability to control SHMT1 activity, in vitro and in vivo,
resulting in signiﬁcant downregulation of its enzymatic
activity.4. Discussion
4.1. Chemical genetic dissection of the regulatory pathways
controlled by Hog1
Speciﬁc labeling of the direct substrates of the mutant kinase
with A*TP, coupled with 2D gel electrophoresis and subse-
quent high-throughput mass spectrometric analyses resulted
in the identiﬁcation of multiple putative substrates of Hog1,
which were further conﬁrmed to be direct substrates of Hog1
in vivo. Our global labeling experiments led to the identiﬁca-
tion of four novel targets of Hog1, Hsp26, Krs1, Tdh3 and
Shm2, which are not transcriptional regulators. According to
their known functions, these novel substrates may have a role
in the regulation of translation, cell metabolism and a protec-
tive role against stress (Fig. 4A and Supplementary Informa-
tion).
Our report describes the ﬁrst comprehensive chemical genet-
ic screen for direct physiological substrates of Hog1 kinase,
revealing four novel players downstream of Hog1 that mediate
these responses in vivo. This screen has uncovered several novel
Hog1 substrates that provide new avenues for investigation
into the mechanism of osmoadaptation by this kinase. More
importantly, the identiﬁcation of these substrates of Hog1 ki-
nase reveals the high degree of functional homology between
yeast and mammalian signaling pathways, validating the use
of yeast as a model system to explore the mammalian counter-
parts of complex signaling systems (Fig. 4B). For example, the
mammalian homolog of a novel substrate of Hog1, Shm2 is
highly expressed in tumor cells and we demonstrate that it is
a novel physiological substrate of p38 MAP kinase. Downreg-ulation of its enzymatic activity was observed following p38-
mediated phosphorylation in vivo, suggesting a potential can-
cer-modulating property of p38 MAP kinase.
Further characterization of the identiﬁed target proteins will
undoubtedly broaden our understanding about the molecular
mechanism of regulation exerted by each protein as well as
the entire regulatory network of Hog1. Also, extending our
combined approaches to other kinases of interest will help us
not only to reveal the details of the molecular mechanism of
a given signaling pathway but also to understand better the
fundamentals of signal transduction networks as a whole in
this proteomic era.
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